112 related articles for article (PubMed ID: 22246525)
1. High co-expression of vascular endothelial growth factor receptor-1 and Snail is associated with poor prognosis after curative resection of hepatocellular carcinoma.
Li T; Zhu Y; Ren W; Xu S; Yang Z; Fang A; Qin C
Med Oncol; 2012 Dec; 29(4):2750-61. PubMed ID: 22246525
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
[TBL] [Abstract][Full Text] [Related]
3. VEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinoma.
Li T; Zhu Y; Han L; Ren W; Liu H; Qin C
Future Oncol; 2015; 11(23):3143-57. PubMed ID: 26551737
[TBL] [Abstract][Full Text] [Related]
4. Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma.
Miyoshi A; Kitajima Y; Kido S; Shimonishi T; Matsuyama S; Kitahara K; Miyazaki K
Br J Cancer; 2005 Jan; 92(2):252-8. PubMed ID: 15668718
[TBL] [Abstract][Full Text] [Related]
5. Prognostic roles of cross-talk between peritumoral hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoral VEGF-C, VEGFR-1 and VEGFR-3.
Zhuang PY; Shen J; Zhu XD; Lu L; Wang L; Tang ZY; Sun HC
PLoS One; 2013; 8(5):e64598. PubMed ID: 23737988
[TBL] [Abstract][Full Text] [Related]
6. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
Zhang Y; Fan Y; Mei Z
Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma.
Dong WW; Mou Q; Chen J; Cui JT; Li WM; Xiao WH
World J Gastroenterol; 2012 Apr; 18(15):1806-13. PubMed ID: 22553406
[TBL] [Abstract][Full Text] [Related]
8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
[TBL] [Abstract][Full Text] [Related]
10. CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma.
Shi GM; Ke AW; Zhou J; Wang XY; Xu Y; Ding ZB; Devbhandari RP; Huang XY; Qiu SJ; Shi YH; Dai Z; Yang XR; Yang GH; Fan J
Hepatology; 2010 Jul; 52(1):183-96. PubMed ID: 20578262
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
[TBL] [Abstract][Full Text] [Related]
13. DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.
Xie B; Lin W; Ye J; Wang X; Zhang B; Xiong S; Li H; Tan G
J Exp Clin Cancer Res; 2015 Sep; 34(1):101. PubMed ID: 26362312
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic significance of the expression of Snail in hepatocellular carcinoma.
Woo HY; Min AL; Choi JY; Bae SH; Yoon SK; Jung CK
Korean J Hepatol; 2011 Mar; 17(1):12-8. PubMed ID: 21494073
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of Bcl-2 with epithelial-mesenchymal transition regulators is a prognostic indicator in hepatocellular carcinoma.
Zhao N; Sun BC; Zhao XL; Liu ZY; Sun T; Qiu ZQ; Gu Q; Che N; Dong XY
Med Oncol; 2012 Dec; 29(4):2780-92. PubMed ID: 22460834
[TBL] [Abstract][Full Text] [Related]
16. DLX4 as a prognostic marker for hepatocellular carcinoma.
Gao Y; Li Z; Guo X; Liu Y; Zhang K
Neoplasma; 2014; 61(3):318-23. PubMed ID: 24824934
[TBL] [Abstract][Full Text] [Related]
17. Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival.
Jia JB; Zhuang PY; Sun HC; Zhang JB; Zhang W; Zhu XD; Xiong YQ; Xu HX; Tang ZY
J Cancer Res Clin Oncol; 2009 Jun; 135(6):847-54. PubMed ID: 19066962
[TBL] [Abstract][Full Text] [Related]
18. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
Ahn S; Hyeon J; Park CK
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
[TBL] [Abstract][Full Text] [Related]
19. Significance of relaxin-2 expression in hepatocellular carcinoma: relation with clinicopathological parameters.
Pan HZ; Dong AB; Wang L; Tan SS; Yang Q; Tong XY; Liang J; Wang JR
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1095-101. PubMed ID: 23661524
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
